Literature DB >> 23187948

Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa.

Gesine Meyer-Rath1, Alana T Brennan, Matthew P Fox, Tebogo Modisenyane, Nkeko Tshabangu, Lerato Mohapi, Sydney Rosen, Neil Martinson.   

Abstract

Few studies have compared hospitalizations before and after antiretroviral therapy (ART) initiation in the same patients. We analyzed the cost of hospitalizations among 3906 adult patients in 2 South African hospitals, 30% of whom initiated ART. Hospitalizations were 50% and 40% more frequent and 1.5 and 2.6 times more costly at a CD4 cell count, 100 cells/mm(3) when compared with 200–350 cells/mm(3) in the pre-ART and ART period, respectively. Mean inpatient cost per patient year was USD 117 (95%confidence interval, 85 to 158) for patients on ART and USD 72(95% confidence interval, 56 to 89) for pre-ART patients. Raising ART eligibility thresholds could avoid the high cost of hospitalization before and immediately after ART initiation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23187948      PMCID: PMC3625673          DOI: 10.1097/QAI.0b013e31827e8785

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  30 in total

1.  [Cost effectiveness analysis of highly active antiretroviral therapy in HIV asymptomatic patients].

Authors:  J L Pinto; C López Lavid; X Badia; A Coma; A Benavides
Journal:  Med Clin (Barc)       Date:  2000       Impact factor: 1.725

2.  The cost effectiveness of combination antiretroviral therapy for HIV disease.

Authors:  K A Freedberg; E Losina; M C Weinstein; A D Paltiel; C J Cohen; G R Seage; D E Craven; H Zhang; A D Kimmel; S J Goldie
Journal:  N Engl J Med       Date:  2001-03-15       Impact factor: 91.245

3.  Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

Authors:  P P Sendi; H C Bucher; T Harr; B A Craig; M Schwietert; D Pfluger; A Gafni; M Battegay
Journal:  AIDS       Date:  1999-06-18       Impact factor: 4.177

4.  A prospective evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing antiretroviral treatment regimens in HIV infection. European perspective.

Authors:  L Lacey; M Youle; P Trueman; S Staszewski; M Schrappe; M Behrens
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

5.  The impact of new antiretroic therapeutic schemes on the cost for AIDS treatment in Greece.

Authors:  J E Kyriopoulos; M A Geitona; V A Paparizos; K K Kyriakis; C A Botsi; N G Stavrianeas
Journal:  J Med Syst       Date:  2001-02       Impact factor: 4.460

6.  The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.

Authors:  Hartmut B Krentz; M Christopher Auld; M John Gill
Journal:  CMAJ       Date:  2003-07-22       Impact factor: 8.262

7.  The high cost of medical care for patients who present late (CD4 <200 cells/microL) with HIV infection.

Authors:  H B Krentz; M C Auld; M J Gill
Journal:  HIV Med       Date:  2004-03       Impact factor: 3.180

8.  Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa.

Authors:  Neil Martinson; Lerato Mohapi; Darryl Bakos; Glenda E Gray; James A McIntyre; Charles B Holmes
Journal:  J Acquir Immune Defic Syndr       Date:  2009-03-01       Impact factor: 3.731

9.  Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.

Authors:  Rory Leisegang; Susan Cleary; Michael Hislop; Alistair Davidse; Leon Regensberg; Francesca Little; Gary Maartens
Journal:  PLoS Med       Date:  2009-12-01       Impact factor: 11.069

Review 10.  Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy.

Authors:  Graeme Meintjes; Helena Rabie; Robert J Wilkinson; Mark F Cotton
Journal:  Clin Chest Med       Date:  2009-12       Impact factor: 2.878

View more
  19 in total

1.  The economic benefits of high CD4 counts among people living with HIV/AIDS in Zambia.

Authors:  Nyasha Tirivayi; John R Koethe
Journal:  J Public Health (Oxf)       Date:  2016-12-02       Impact factor: 2.341

2.  Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya.

Authors:  Monisha Sharma; Jennifer A Smith; Carey Farquhar; Roger Ying; Peter Cherutich; Matthew Golden; Beatrice Wamuti; David Bukusi; Hans Spiegel; Ruanne V Barnabas
Journal:  AIDS       Date:  2018-01-14       Impact factor: 4.177

3.  PrEP Implementation Science: State-of-the-Art and Research Agenda.

Authors:  Carlos F Cáceres; Kenneth H Mayer; Rachel Baggaley; Kevin R O'Reilly
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

4.  HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.

Authors:  Gesine Meyer-Rath; Mead Over
Journal:  PLoS Med       Date:  2012-07-10       Impact factor: 11.069

5.  Editorial commentary: immunodeficiency at start of antiretroviral therapy: the persistent problem of late presentation to care.

Authors:  Nathan Ford; Edward J Mills; Matthias Egger
Journal:  Clin Infect Dis       Date:  2014-12-16       Impact factor: 9.079

6.  Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda.

Authors:  Roger Ying; Monisha Sharma; Renee Heffron; Connie L Celum; Jared M Baeten; Elly Katabira; Nulu Bulya; Ruanne V Barnabas
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

7.  Predictors of Late Presentation for HIV/AIDS in West Arsi Zone Public Health Institutions, South Ethiopia: Unmatched Case-Control Study.

Authors:  Sisay Degno; Daniel Atlaw; Ashenafi Mekonnen; Bikila Lencha; Kebede Kumsa; Yohannes Tekalegn; Gashaw Walle; Ashebir Niggussie; Rameto Aman
Journal:  HIV AIDS (Auckl)       Date:  2021-07-13

8.  HIV Treatment Substantially Decreases Hospitalization Rates: Evidence From Rural South Africa.

Authors:  Jan A C Hontelez; Jacob Bor; Frank C Tanser; Deenan Pillay; Mosa Moshabela; Till Bärnighausen
Journal:  Health Aff (Millwood)       Date:  2018-06       Impact factor: 9.048

9.  The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis.

Authors:  Gesine Meyer-Rath; Jan Pienaar; Brian Brink; Andrew van Zyl; Debbie Muirhead; Alison Grant; Gavin Churchyard; Charlotte Watts; Peter Vickerman
Journal:  PLoS Med       Date:  2015-09-01       Impact factor: 11.069

10.  The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa.

Authors:  Lawrence C Long; Matthew P Fox; Celeste Sauls; Denise Evans; Ian Sanne; Sydney B Rosen
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.